Literature DB >> 34848064

Fluid management considerations in extremely preterm infants born at 22-24 weeks of gestation.

Johan Ågren1, Jeffrey L Segar2, Fanny Söderström3, Edward F Bell4.   

Abstract

Emerging data regarding the encouraging outcomes of extremely preterm infants from centers taking active approaches to the care of these infants have prompted dialogue regarding optimal medical management. Among the multitude of decisions providers make in caring for extremely premature infants is the prescribing of parenteral fluids. Surprisingly, there are limited data to guide evidenced-based approaches to fluid and electrolyte management in this population. Immaturity of renal function and skin barriers contribute to the impaired capacity of the preterm infant to maintain salt and water homeostasis. This perspective paper highlights developmental physiological properties of the kidney and skin, which the provider needs to understand to provide parenteral fluid therapy. Additionally, we provide recommendations for initial fluid and electrolyte management of the preterm infant based on novel data as well as the published literature.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Electrolyte; Hyperosmolarity; Insensible water loss; Prematurity; Sodium; Transepidermal

Mesh:

Substances:

Year:  2021        PMID: 34848064     DOI: 10.1016/j.semperi.2021.151541

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  2 in total

1.  The Impact of Restricted versus Liberal Early Fluid Volumes on Plasma Sodium, Weight Change, and Short-Term Outcomes in Extremely Preterm Infants.

Authors:  Barbro Diderholm; Erik Normann; Fredrik Ahlsson; Richard Sindelar; Johan Ågren
Journal:  Nutrients       Date:  2022-02-14       Impact factor: 5.717

2.  Thermoregulation and golden hour practices in extremely preterm infants: an international survey.

Authors:  Pranav Jani; Umesh Mishra; Julia Buchmayer; Karen Walker; Duygu Gözen; Rajesh Maheshwari; Daphne D'Çruz; Krista Lowe; Audrey Wright; James Marceau; Mihaela Culcer; Archana Priyadarshi; Adrienne Kirby; James E Moore; Ju Lee Oei; Vibhuti Shah; Umesh Vaidya; Abdelmoneim Khashana; Sunit Godambe; Fook Choe Cheah; Wenhao Zhou; Hu Xiaojing; Muneerah Satardien
Journal:  Pediatr Res       Date:  2022-09-08       Impact factor: 3.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.